News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Andreas Brandl: Prophylactic use of HIPEC in T4 colorectal cancer at ESSO43
Photo from Andreas Brandl/X
Oct 5, 2024, 09:24

Andreas Brandl: Prophylactic use of HIPEC in T4 colorectal cancer at ESSO43

Andreas Brandl, Co-Chair Education & Training Commitee ESSO, shared a post on X:

“Starting a fresh day with imaging for peritoneal Mets in follow up In Okapi Room at ESSO43.

Fantastic talk of Dresen Elleke.

Come and join our debate about prophylactic use of HIPEC in T4 colorectal cancer.”

Andreas Brandl: Prophylactic use of HIPEC in T4 colorectal cancer at ESSO43

Source: Andreas Brandl/X

 

Andreas Brandl cancer cancer awareness cancer care colorectal cancer Dresen Elleke ESSO ESSO43 fight against cancer Global fight against cancer HIPEC OncoDaily Oncology
Special Coverage
Blog
Oct 5, 2024, 09:24
Andreas Brandl: Prophylactic use of HIPEC in T4 colorectal cancer at ESSO43
Blog
Oct 5, 2024, 09:22
Doublet Immunotherapy Options for Unresectable Hepatocellular Carcinoma
Insight
Oct 5, 2024, 09:20
DESTINY-Breast06 is the first study to investigate a HER2-directed therapy in patients with HER2-ultralow tumors - ASCO
Blog
Oct 5, 2024, 09:17
Mark Lawler: Economist Impact taking money from Big Tobacco while running heath conferences
Blog
Oct 5, 2024, 09:16
Jame Abraham: Shlomo Koyfman appointed as the Director of Precision Oncology Program at Cleveland Clinic
Blog
Oct 5, 2024, 09:15
Zainab Shinkafi-Bagudu: Fostering Global health equity through my work
Blog
Oct 5, 2024, 09:11
Owkin is entering a new partnership with AstraZeneca to develop a gBRCA pre-screening solution in breast cancer directly from digitised pathology slides
Insight
Oct 5, 2024, 09:09
Sunil Verma: AstraZeneca’s vision to redefine cancer care
Insight
Oct 5, 2024, 09:06
Michael Chuong: Incredible 5 days at the ASTRO annual meeting
Insight
Oct 5, 2024, 08:59
Palvella is the recipient of an FDA Orphan Product Grant up to $2.6 million
Insight
Oct 5, 2024, 08:53
Julia Shi: Great time at ASTRO24 with my fellow UTSW medical students
Insight
Oct 5, 2024, 08:51
ICCD Campaign highlights urgent global challenges in childhood cancer care